by Cedars-Sinai Medical Center Graphical abstract. Credit: Nano Today (2023). DOI: 10.1016/j.nantod.2022.101746 Cedars-Sinai Cancer investigators have developed a new nanotechnology-based test that can detect and profile prostate cancers—even in microscopic amounts. Their work, published in the journal Nano Today, suggests that this “liquid biopsy” test could spare many patients unnecessary treatment-related side effects, directing them instead to effective therapies...
Tag: <span>noninvasive test</span>
Post
Study finds less expensive noninvasive test is an effective alternative for colorectal cancer screening
by American College of Surgeons Non-invasive, less expensive test is effective in early-stage colorectal cancer screening. Credit: American College of Surgeons Commercially available noninvasive screening tests for colorectal cancer—a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard®)—are equally effective for screening patients with early-stage colorectal cancer. However, a FIT costs about...